Markets › India › BOM › 544312

Hamps Bio Ltd

BOM:544312Health Technology

₹25.00+2.04%At closeAt close · Mon 19 Oct · ≈ AED 0.9659 · Market cap $2.25M

🔔 Alert▶ Test a strategy

Ratio	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025	Trend	YoY
Gross margin	14.2%	14.2%	20.2%	29.3%	22.6%	6.0%		−16.6 pts
Operating margin	—	5.4%	9.5%	11.9%	5.9%	−9.2%		−15.1 pts
Net margin	2.3%	2.3%	6.4%	7.7%	4.5%	−8.7%		−13.2 pts
EBITDA margin	11.5%	11.5%	15.5%	18.2%	11.5%	0.4%		−11.1 pts
Return on equity	—	12.1%	26.3%	15.0%	3.4%	−9.1%		−12.5 pts
Return on assets	3.3%	3.3%	9.1%	9.8%	2.3%	−4.6%		−7.0 pts
Return on capital employed	—	15.8%	28.0%	20.8%	3.6%	−6.3%		−9.9 pts
Debt / equity	—	2.0×	1.3×	0.3×	0.3×	0.8×		+152.0%
Debt / assets	56.1%	56.1%	43.9%	20.4%	23.2%	43.2%		+20.0 pts
Interest coverage	0.0×	1.5×	3.0×	5.2×	2.8×	−3.1×		−211.3%
Current ratio	—	0.7×	0.6×	1.7×	2.3×	1.5×		−36.3%
Quick ratio	—	0.4×	0.4×	0.9×	1.0×	0.7×		−25.6%
Cash ratio	—	0.0×	0.0×	0.0×	0.1×	0.0×		−8.3%
Asset turnover	1.5×	1.5×	1.4×	1.3×	0.5×	0.5×		+2.1%
Inventory turnover	—	8.1×	12.1×	3.7×	2.1×	3.0×		+43.5%
Receivables turnover	—	7.7×	7.3×	6.4×	3.9×	3.4×		−12.1%
Dividend payout	—	0.0%	0.0%	0.0%	0.0%	0.0%		—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

544312 · Ratios · TradingHolo